Confort at Home SRL
Confort at Home reported total assets of 7,413 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of Confort at Home shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -67 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Confort at Home's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 26 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 30 Aug 2022
Confort at Home's financial analysis
- Solvency-673.7%sector median: 32.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Confort at Home
Confort at Home's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0737.633.035
- VAT number
- BE0737633035
- Peppol
- Registered · 0208:0737633035 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Nov 2019
- Registered office
- 1070 Anderlecht
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Confort at Home (SRL) has been based in Anderlecht since 2019, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 7,034 € and equity of −49,937 €; its revenue is not published. Its solvency stands at -673.7%, below the median of its sector (32.3%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Confort at Home
Companies in the same business, of comparable size and area, outside its group.
- Novalab Wholesale of pharmaceutical and medical goods Uccle · balance sheet 113,734 €
- OTC Focus Wholesale of pharmaceutical and medical goods Chastre · balance sheet 27,302 €
- Hexacath Belgium Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 96,025 €
- OTC Diffusion Activities of agents involved in the wholesale of furniture, household goods, hardware and ironmongery Saint-Gilles · balance sheet 318,948 €
- Taikun Pharmaceutical Technology Manufacture of basic pharmaceutical products Ghent · balance sheet 275,396 €
- Extraphar Wholesale of pharmaceutical and medical goods Woluwe-Saint-Lambert · balance sheet 10,258 €
- Orthophysics Manufacture of medical and dental instruments and supplies Hooglede · balance sheet €2.78m
- ACDcure Wholesale of pharmaceutical and medical goods Nazareth-De Pinte · balance sheet 17,329 €
Frequently asked questions about Confort at Home
What is the revenue of Confort at Home?
Confort at Home files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Confort at Home?
In Belgium, the VAT number is the company number prefixed with BE: BE0737633035 for Confort at Home, if the company is VAT-registered. Its company number (CBE) is 0737.633.035.
Where is the registered office of Confort at Home?
According to the CBE register, the registered office of Confort at Home is in 1070 Anderlecht.
What is the equity of Confort at Home?
At the close of the 2025 financial year, the equity of Confort at Home amounts to -49,937 €, a solvency of -673.7% of total assets.
Who manages Confort at Home?
The register lists 2 active mandates at Confort at Home. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Confort at Home
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →